Ocular Safety of Recombinant Zoster Vaccination in Adults Aged 50 Years and Older: A Propensity-Matched Real-World Cohort Study. Kozlov M, Stratigakis N, Syal S, Gadaria N Ocul Immunol Inflamm. 2026 Sep 29:1-6. PMID: 42811473. Abstract CommentRecommendBookmarkWatch
